March 4, 2026
Agentic AI in Life Sciences (Part 2) explores how agent-based AI systems move beyond chatbots into goal-driven, tool-using, multi-step workflows—and what that means for biotech, pharma, healthcare R&D, and regulated environments. In this episode, we go deeper into multi-agent architectures, real-world use cases, validation strategies, and governance so teams can adopt agentic AI safely and effectively. If you’re evaluating AI for drug discovery, biomarker research, clinical operations, pharmacov...